loadpatents
name:-0.20940899848938
name:-0.020771980285645
name:-0.15997695922852
Meyer; Everett Hurteau Patent Filings

Meyer; Everett Hurteau

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meyer; Everett Hurteau.The latest application filed is for "blockade of rgmb for treating inflammatory bowel disease and colitis".

Company Profile
10.12.25
  • Meyer; Everett Hurteau - Belmont CA
  • Meyer; Everett Hurteau - Redwood City CA
  • Meyer; Everett Hurteau - Reston VA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for allogenic hematopoietic stem cell transplantation
Grant 11,447,747 - Meyer , et al. September 20, 2
2022-09-20
BLOCKADE OF RGMb FOR TREATING INFLAMMATORY BOWEL DISEASE AND COLITIS
App 20220267428 - Meyer; Everett Hurteau ;   et al.
2022-08-25
System And Methods For Massively Parallel Analysis Of Nucleic Acids In Single Cells
App 20220056522 - Johnson; David Scott ;   et al.
2022-02-24
Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases
Grant 11,246,890 - Lin , et al. February 15, 2
2022-02-15
System And Methods For Massively Parallel Analysis Of Nucleic Acids In Single Cells
App 20210292835 - Johnson; David Scott ;   et al.
2021-09-23
System and methods for massively parallel analysis of nucleic acids in single cells
Grant 11,053,543 - Johnson , et al. July 6, 2
2021-07-06
Methods For Allogenic Hematopoietic Stem Cell Transplantation
App 20210030797 - Meyer; Everett Hurteau ;   et al.
2021-02-04
Methods For Allogenic Hematopoietic Stem Cell Transplantation
App 20210015862 - Meyer; Everett Hurteau ;   et al.
2021-01-21
Methods For Allogenic Hematopoietic Stem Cell Transplantation
App 20210002613 - Meyer; Everett Hurteau ;   et al.
2021-01-07
System and methods for massively parallel analysis of nucleic acids in single cells
Grant 10,787,706 - Johnson , et al. September 29, 2
2020-09-29
System And Methods For Massively Parallel Analysis Of Nucleic Acids In Single Cells
App 20200291474 - Johnson; David Scott ;   et al.
2020-09-17
Blockade of RGMB for reducing transplantation-associated inflammation leading to loss of function of a transplanted organ in a graft recipient
Grant 10,669,335 - Meyer , et al.
2020-06-02
System And Methods For Massively Parallel Analysis Of Nucleic Acids In Single Cells
App 20200140947 - Johnson; David Scott ;   et al.
2020-05-07
System and methods for massively parallel analysis of nucleic acids in single cells
Grant 10,465,243 - Johnson , et al. No
2019-11-05
Regulatory T Cells Targeted With Chimeric Antigen Receptors
App 20190307795 - Tang; Sai-Wen ;   et al.
2019-10-10
Systemic Targeting Of Inflammatory Sites And Enhanced Immunomodulatory Function By Introducing The Chimeric Antigen Receptor (ca
App 20190298774 - Lin; Tzuhua Dennis ;   et al.
2019-10-03
BLOCKADE OF RGMb FOR REDUCING TRANSPLANTATION-ASSOCIATED IMMUNE RESPONSES
App 20190077861 - Meyer; Everett Hurteau ;   et al.
2019-03-14
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
App 20190002974 - Johnson; David Scott ;   et al.
2019-01-03
System and methods for massively parallel analysis of nucleic acids in single cells
Grant 10,106,789 - Johnson , et al. October 23, 2
2018-10-23
Blockade of RGMb for reducing transplantation-associated immune responses
Grant 10,093,734 - Meyer , et al. October 9, 2
2018-10-09
Enhanced Regulatory T Cells Targeted To Sites Of Inflammation With Chimeric Antigen Receptors And Expressing Factors That Enhance Viability Of Pancreatic Cells
App 20170274095 - Meyer; Everett Hurteau ;   et al.
2017-09-28
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
App 20170204460 - Johnson; David Scott ;   et al.
2017-07-20
System and methods for massively parallel analysis of nucleic acids in single cells
Grant 9,695,474 - Johnson , et al. July 4, 2
2017-07-04
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
App 20170166889 - Johnson; David Scott ;   et al.
2017-06-15
BLOCKADE OF RGMb FOR REDUCING TRANSPLANTATION-ASSOCIATED IMMUNE RESPONSES
App 20170121404 - Meyer; Everett Hurteau ;   et al.
2017-05-04
Blockade Of Tim-1 For Treating Graft-versus-host Disease
App 20170101471 - Iliopoulou; Panagiota ;   et al.
2017-04-13
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
App 20160326583 - Johnson; David Scott ;   et al.
2016-11-10
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
App 20150344871 - JOHNSON; DAVID SCOTT ;   et al.
2015-12-03
System and Methods for Genetic Analysis of Mixed Cell Populations
App 20150154352 - Johnson; David Scott ;   et al.
2015-06-04
Methods for relieving asthma-associated airway hyperresponsiveness
Grant 8,679,499 - Strober , et al. March 25, 2
2014-03-25
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
App 20140057799 - Johnson; David Scott ;   et al.
2014-02-27
Treatment Of Airway Hyperreactivity
App 20110300154 - Umetsu; Dale T. ;   et al.
2011-12-08
Methods For Inhibition Of Nkt Cells
App 20100197613 - Strober; Samuel ;   et al.
2010-08-05
Methods for inhibition of NKT cells
Grant 7,682,614 - Strober , et al. March 23, 2
2010-03-23
Methods for inhibition of NKT cells
App 20060116332 - Strober; Samuel ;   et al.
2006-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed